{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:02:17Z","timestamp":1776978137372,"version":"3.51.4"},"reference-count":44,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"4","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>In 2023, the G7 Cancer Initiative was launched by Australia, Canada, France, Germany, Japan, the United Kingdom, and the United States with the aim of enhancing global cancer control, and with poor-prognosis cancers as a priority. To facilitate effective collaboration among G7 Cancer, we aimed to address the lack of standardized definitions and coordinated initiatives across countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We examined how the G7 Cancer Initiative countries defined poor-prognosis cancers, objectively classified them, quantified their burden, and assessed national response strategies. A review of national cancer plans was conducted together with an expert email survey to evaluate definitions and classifications. Poor-prognosis cancers were identified based on 5-year net survival (NS) below 30% and a mortality-to-incidence (M\/I) ratio over 0.75 using CONCORD-3 and Global Cancer Observatory 2022 data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Pancreatic cancer was consistently categorized as a poor-prognosis cancer, while some countries also included liver, esophageal, stomach, and some brain cancers. For lung cancer, classification varied depending on the definition used. These six cancers accounted for a major share of cancer deaths, with lung (18%-23%) and pancreatic (6%-10%) cancers contributing the most. National strategies differed, with Australia, France, and Japan implementing specific policies for poor-prognosis cancers, while others addressed them indirectly or not at all.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>To enhance cancer outcomes for poor-prognosis cancers, the G7 Cancer Initiative should coordinate efforts through joint programs focused on early detection, treatment, and policy alignment. Standardized definitions and collaborative action are essential to strengthening the global poor-prognosis cancer response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00483","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:59:12Z","timestamp":1776974352000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0712-2505","authenticated-orcid":true,"given":"Marisa","family":"Nishio","sequence":"first","affiliation":[{"name":"Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan"},{"name":"Department of Medical Statistics, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-0865","authenticated-orcid":true,"given":"Hiromi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7397-3442","authenticated-orcid":true,"given":"Valerie","family":"McCormack","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer (IARC\/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Viguier","sequence":"additional","affiliation":[{"name":"Institut National du Cancer\u2014French National Cancer Institute, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Quesnel","sequence":"additional","affiliation":[{"name":"Institut National du Cancer\u2014French National Cancer Institute, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-2237","authenticated-orcid":true,"given":"Juan","family":"Iovanna","sequence":"additional","affiliation":[{"name":"Aix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6161-8483","authenticated-orcid":true,"given":"Nelson","family":"Dusetti","sequence":"additional","affiliation":[{"name":"Aix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Hammel","sequence":"additional","affiliation":[{"name":"Paris-Saclay University, Digestive and Medical Oncology Department, Paul Brousse Hospital, APHP, Villejuif, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Charlotte","family":"Henrion","sequence":"additional","affiliation":[{"name":"Institut National du Cancer\u2014French National Cancer Institute, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-2744","authenticated-orcid":true,"given":"Cecilia","family":"Monge","sequence":"additional","affiliation":[{"name":"Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"McKay","sequence":"additional","affiliation":[{"name":"Cancer Research UK, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2919-4326","authenticated-orcid":true,"given":"Alice","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, NCI, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3828-8620","authenticated-orcid":true,"given":"Karol","family":"Nowicki-Osuch","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ) Heidelberg, Tumorigenesis and Molecular Cancer Prevention Group, Heidelberg, Germany"},{"name":"DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Abe","sequence":"additional","affiliation":[{"name":"Economic Research Institute for ASEAN and East Asia, Jakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6765-6499","authenticated-orcid":true,"given":"Mayo","family":"Hirabayashi","sequence":"additional","affiliation":[{"name":"Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-5933","authenticated-orcid":true,"given":"Marina","family":"Tanitame","sequence":"additional","affiliation":[{"name":"Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9809-5164","authenticated-orcid":true,"given":"Tetsuya","family":"Tajima","sequence":"additional","affiliation":[{"name":"Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1276-2398","authenticated-orcid":true,"given":"Manami","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan"},{"name":"Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7311-1233","authenticated-orcid":true,"given":"Tomohiro","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Division of International Health Policy Research, Institution for Cancer Control, National Cancer Center, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2017.02.002"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9040"},{"key":"e_1_3_8_4_2","first-page":"e1764","article-title":"Technological advancements in cancer diagnostics: Improvements and limitations","volume":"6","author":"Pulumati A","year":"2023","unstructured":"Pulumati A, Pulumati A, Dwarakanath BS, et al: Technological advancements in cancer diagnostics: Improvements and limitations. Cancer Rep 6:e1764, 2023","journal-title":"Cancer Rep"},{"key":"e_1_3_8_5_2","volume-title":"Mayo Clinic Q and A: 5 Advances in Cancer Treatment","author":"Weiss C","year":"2023","unstructured":"Weiss C. Mayo Clinic Q and A: 5 Advances in Cancer Treatment. Rochester, MN: Mayo Clinic News Network; https:\/\/newsnetwork.mayoclinic.org\/discussion\/mayo-clinic-q-and-a-5-advances-in-cancer-treatment\/ (2023)."},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/wvn.12621"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00236-X"},{"key":"e_1_3_8_9_2","unstructured":"Cancer Australia: Australian Cancer Plan. Sydney NSW Australia Cancer Australia. 2023. https:\/\/www.australiancancerplan.gov.au\/welcome"},{"key":"e_1_3_8_10_2","unstructured":"Canadian Partnership Against Cancer: Canadian Strategy for Cancer Control 2019-2029: Doing together what cannot be done alone. Toronto ON Canada Canadian Partnership Against Cancer. 2019. https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2019\/06\/Canadian-Strategy-Cancer-Control-2019-2029-EN.pdf"},{"key":"e_1_3_8_11_2","unstructured":"Institut national du cancer: Strat\u00e9gie d\u00e9cennale de lutte contre les cancers 2021-2030 deuxi\u00e8me rapport au pr\u00e9sident de la r\u00e9publique. 2023. https:\/\/www.e-cancer.fr\/content\/download\/462633\/7004699\/file\/Strat%C3%A9gie%20d%C3%A9cennale%20de%20lutte%20contre%20les%20cancers%202021-2030 %20deuxi%C3%A8me%20rapport%20au%20pr%C3%A9sident%20de%20la%20R%C3%A9publique.pdf"},{"key":"e_1_3_8_12_2","unstructured":"Federal Ministry of Health: Nationaler Krebsplan. Bonn Germany Bundesministerium f\u00fcr Gesundheit. 2018. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Praevention\/Broschueren\/Broschuere_Nationaler_Krebsplan.pdf"},{"key":"e_1_3_8_13_2","unstructured":"Ministry of Health Labour and Welfare: The Fourth Basic Plan for Promotion of Cancer Control. Tokyo Japan Ministry of Health Labour and Welfare. 2023. https:\/\/www.mhlw.go.jp\/content\/10900000\/001138884.pdf"},{"key":"e_1_3_8_14_2","unstructured":"NHS: The NHS long term plan. 2019. https:\/\/www.longtermplan.nhs.uk\/"},{"key":"e_1_3_8_15_2","volume-title":"Nationalcancerplan\u2014National Cancer Institute","author":"National Cancer Plan-Everyone Has a Role","year":"2023","unstructured":"National Cancer Plan-Everyone Has a Role: Nationalcancerplan\u2014National Cancer Institute. 2023. https:\/\/nationalcancerplan.cancer.gov\/"},{"key":"e_1_3_8_16_2","volume-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay J","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al: Global Cancer Observatory: Cancer Today. Lyon, France, International Agency for Research on Cancer. https:\/\/gco.iarc.fr\/today\/en"},{"key":"e_1_3_8_17_2","unstructured":"Reference deleted"},{"key":"e_1_3_8_18_2","unstructured":"Less Survivable Cancers Taskforce: Less Survivable Cancers Taskforce. London UK Less Survivable Cancers Taskforce. 2018. https:\/\/lesssurvivablecancers.org.uk\/"},{"key":"e_1_3_8_19_2","unstructured":"Cancer Research UK: Research in Cancers of Unmet Need. London UK Cancer Research UK. (n.d.). https:\/\/www.cancerresearchuk.org\/for-researchers\/our-research-strategy\/research-in-cancers-of-unmet-need"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195149616.001.0001"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303108"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3247"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.18.20901"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903387"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208470"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.06.010"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.05.032"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0950"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030949"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000264"},{"key":"e_1_3_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.11.012"},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0281"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31099-0"},{"key":"e_1_3_8_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.322"},{"key":"e_1_3_8_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305372"},{"key":"e_1_3_8_36_2","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.90.251"},{"key":"e_1_3_8_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyy077"},{"key":"e_1_3_8_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01729-0"},{"key":"e_1_3_8_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00639-9"},{"key":"e_1_3_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2019.12.003"},{"key":"e_1_3_8_41_2","doi-asserted-by":"publisher","DOI":"10.1159\/000367727"},{"key":"e_1_3_8_42_2","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2022.0586"},{"key":"e_1_3_8_43_2","unstructured":"PRECEDE Consortium. The pancreatic cancer early detection (PRECEDE) Consortium. La Jolla CA. PRECEDE Consortium. 2020. https:\/\/precedestudy.org\/."},{"key":"e_1_3_8_44_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.7097"},{"key":"e_1_3_8_45_2","unstructured":"Federal Ministry of Education and Research. National decade against cancer: Die nationale dekade gegen krebs. Bonn Germany: Federal Ministry of Education and Research; https:\/\/www.dekade-gegen-krebs.de\/en\/home\/home_node.html (2020)."}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:59:30Z","timestamp":1776974370000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1200\/GO-25-00483"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00483","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-08-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500483"}}